Testing IRL757 for apathy in Parkinson's disease
Part of Brain & nervous system clinical trials.
This trial tests a new drug called IRL757 to see if it is safe and helps with apathy (loss of motivation or interest) in people with Parkinson's disease. You need to have at least moderate apathy and a caregiver who can come to visits with you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 90 years old with Parkinson's disease.
- You have had apathy (like less interest, less motivation, or less emotion) for at least 4 weeks that is clearly different from your usual self.
- You score at least 20 on a thinking and memory test (MoCA).
- You have a caregiver who spends over 10 hours a week with you and can come to study visits.
- Your Parkinson's medications have been stable for at least 1 month and can stay stable during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether methylphenidate can reduce apathy (lack of motivation) in people with Parkinson’s disease. It may help if apathy has been persistent for weeks and your Parkinson’s medicines have been stable.
This trial is testing whether a type of deep brain stimulation (called VC/VS-DBS) can help people with Parkinson's disease who have severe apathy (a loss of interest or motivation) that hasn't gotten better with medication. The goal is to see if this treatment can improve motivation and quality of life.
This study tests a new single-dose treatment for Parkinson's disease to see if it can help reduce 'off' time—when medication wears off and symptoms return. It is for people who experience motor fluctuations and are already on a stable medication routine.
This study tests whether music can help reduce apathy (low motivation) in people with Parkinson’s disease. It may help your mood and daily drive by targeting brain and behavior pathways tied to apathy.
This trial tests whether a medication used for Parkinson's disease (carbidopa-levodopa) can help people with major depression who have lost interest or pleasure in things. It is for adults who have not been helped enough by other treatments and have signs of inflammation.
This study tests whether a non-invasive brain stimulation treatment called TMS (transcranial magnetic stimulation) can help improve apathy, or loss of motivation, in people with Parkinson's disease. You must have had symptoms for at least 4 years and be on stable Parkinson's medications.
Hear when a new PARKINSON DISEASE (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.